You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

post-transplant lymphoproliferative disorder

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

Not yet recruiting
  • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
  • Polymorphic Post-Transplant Lymphoproliferative Disorder
  • Biopsy
  • +5 more
  • New Brunswick, New Jersey
  • +2 more
Mar 23, 2023

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

Not yet recruiting
  • Post-Transplant Lymphoproliferative Disorder
  • +10 more
  • Loncastuximab Tesirine
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2022

Early Detection of Epstein-Barr Virus Related Disease.

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • +8 more
    • Aarhus, Central Region Of Denmark, Denmark
      Aarhus University Hospital
    Dec 12, 2022

    Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

    Recruiting
    • Epstein-Barr Virus Infections
    • +2 more
    • Group A
    • Group B
    • Montreal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont
    Apr 5, 2022

    Epstein-Barr Virus Infections Trial in Strasbourg (Rituximab, control group)

    Recruiting
    • Epstein-Barr Virus Infections
    • Strasbourg, France
      Les Hôpitaux Universitaires de Strasbourg
    Dec 7, 2021

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

    Completed
    • Posttransplant Lymphoproliferative Disorder
    • Rituximab sc
    • +3 more
    • Aachen, Germany
    • +17 more
    Aug 22, 2022

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    May 6, 2022

    Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,

    Active, not recruiting
    • Pediatric Heart Transplantation
    • +6 more
    • Birmingham, Alabama
    • +24 more
    Sep 2, 2021

    Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

    Active, not recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +13 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 8, 2022

    Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disease
    • Transplant-Related Hematologic Malignancy
    • Autologous EBV-CTL transduced with vector SFG-CNA12
    • +2 more
    • London, United Kingdom
    • +1 more
    Jan 19, 2022

    Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,

    Recruiting
    • Primary Immune Regulatory Disorder
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 15, 2023

    Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

    Recruiting
    • Immune Deficiency Disorders
    • +13 more
    • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
    • Saint Louis, Missouri
      Washington University
    Apr 25, 2022

    Urinary Tract Infections, Transplant-Related Disorder Trial in Tehran (Phage)

    Recruiting
    • Urinary Tract Infections
    • Transplant-Related Disorder
    • Phage
    • Tehran, Iran, Islamic Republic of
      Nooshin Dalili
    Jul 21, 2023

    EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

    Not yet recruiting
    • EBV Lymphoma
    • Post-transplant Lymphoproliferative Disease (PTLD)
    • Donor-derived ex-vivo expanded EBV Tscm CTL
    • Basel, Switzerland
    • +7 more
    Jan 25, 2023

    Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

    Active, not recruiting
    • Multiple Myeloma
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +8 more
    May 24, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Recruiting
    • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +4 more
    • tabelecleucel
    • Duarte, California
    • +70 more
    Jun 23, 2022

    Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

    Available
    • Epstein-Barr Virus (EBV) Infections
    • +11 more
    • tabelecleucel
    • (no location specified)
    Feb 15, 2022

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +18 more
    • Scottsdale, Arizona
    • +1 more
    Sep 28, 2020

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    During Pediatric Transplantation: Pre/Post-stages and at 6

    Recruiting
    • Transplant-Related Disorder
    • Allogeneic hematopoietic stem cell transplantation
    • Solid organ transplantation
    • Madrid, Spain
    • +1 more
    Jun 27, 2022

    Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

    Recruiting
    • Epstein-Barr Virus (EBV)-Associated Diseases
    • +13 more
    • Tabelecleucel
    • Los Angeles, California
    • +39 more
    Nov 9, 2022